share_log

Verition Fund Management LLC Invests $515,000 in Universal Health Services, Inc. (NYSE:UHS)

Defense World ·  Sep 24, 2022 04:31

Verition Fund Management LLC purchased a new position in Universal Health Services, Inc. (NYSE:UHS – Get Rating) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,550 shares of the health services provider's stock, valued at approximately $515,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Spire Wealth Management grew its stake in shares of Universal Health Services by 131.1% in the first quarter. Spire Wealth Management now owns 208 shares of the health services provider's stock worth $30,000 after purchasing an additional 118 shares in the last quarter. Parallel Advisors LLC boosted its stake in Universal Health Services by 50.6% during the first quarter. Parallel Advisors LLC now owns 244 shares of the health services provider's stock valued at $36,000 after buying an additional 82 shares in the last quarter. Quent Capital LLC bought a new position in Universal Health Services during the fourth quarter valued at about $43,000. Ancora Advisors LLC boosted its stake in Universal Health Services by 33.3% during the first quarter. Ancora Advisors LLC now owns 400 shares of the health services provider's stock valued at $53,000 after buying an additional 100 shares in the last quarter. Finally, Fifth Third Bancorp boosted its stake in Universal Health Services by 10.9% during the first quarter. Fifth Third Bancorp now owns 692 shares of the health services provider's stock valued at $100,000 after buying an additional 68 shares in the last quarter. Institutional investors own 88.93% of the company's stock.

Get Universal Health Services alerts:

Universal Health Services Stock Down 1.9 %

Shares of Universal Health Services stock opened at $91.75 on Friday. The firm has a market cap of $6.69 billion, a price-to-earnings ratio of 9.34, a P/E/G ratio of 2.87 and a beta of 1.20. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.22 and a quick ratio of 1.12. Universal Health Services, Inc. has a 52-week low of $89.87 and a 52-week high of $158.28. The stock has a 50-day simple moving average of $104.66 and a 200-day simple moving average of $119.25.

Universal Health Services (NYSE:UHS – Get Rating) last announced its quarterly earnings results on Monday, July 25th. The health services provider reported $2.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.12. The business had revenue of $3.32 billion during the quarter, compared to analyst estimates of $3.27 billion. Universal Health Services had a return on equity of 12.88% and a net margin of 5.94%. The firm's revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the company earned $3.76 EPS. On average, equities research analysts expect that Universal Health Services, Inc. will post 9.94 earnings per share for the current fiscal year.

Universal Health Services Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 15th. Shareholders of record on Thursday, September 1st were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Wednesday, August 31st. This represents a $0.80 annualized dividend and a yield of 0.87%. Universal Health Services's dividend payout ratio (DPR) is presently 8.15%.

Analyst Ratings Changes

Several brokerages recently weighed in on UHS. Barclays decreased their target price on Universal Health Services from $133.00 to $115.00 in a research note on Friday, July 29th. Cowen decreased their price target on Universal Health Services to $119.00 in a research report on Tuesday, August 9th. BMO Capital Markets lowered Universal Health Services from a "market perform" rating to an "underperform" rating and decreased their price target for the company from $133.00 to $90.00 in a research report on Wednesday, July 6th. Mizuho decreased their price target on Universal Health Services from $153.00 to $121.00 and set a "buy" rating for the company in a research report on Friday, July 1st. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on Universal Health Services from $160.00 to $130.00 in a research report on Wednesday, July 27th. Five investment analysts have rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $119.57.

Universal Health Services Company Profile

(Get Rating)

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Featured Articles

  • Get a free copy of the StockNews.com research report on Universal Health Services (UHS)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • Will Crowdstrike Get A Boost From Increased EPS Guidance?

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS – Get Rating).

Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment